Stock Market Live June 22, 2026: S&P 500 (SPY) Little Changed as Markets Wait on Iran Progress

Investing

Biogen : BIIB

All Biogen Articles

606 Articles

Jon C. Ogg | Nov 12, 2019 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Tuesday's top analyst upgrades, downgrades and initiations included Albermarle, Amgen, Applied Materials, Biogen, CRISPR Therapeutics, CrowdStrike, CSX, Kroger, Slack, Teva…

Chris Lange | Oct 30, 2019 at 1:05 PM EDT

Multiple Sclerosis Treatment Wins Big FDA Approval

Biogen and Alkermes have announced that the FDA approved Vumerity for the treatment of relapsing forms of multiple sclerosis.

Chris Lange | Oct 25, 2019 at 10:05 AM EDT

Major Biotechs See Rising Tide in Short Interest

The October 15 short interest data has been compared with the previous report, and short interest in most of these…

Lee Jackson | Oct 23, 2019 at 9:45 AM EDT

Top Analysts Upgrades and Downgrades: Biogen, Coke, Crowdstrike, Kohl’s, ServiceNow, Snap, Travelers and More

Wednesday's top analyst upgrades, downgrades and initiations included Biogen, Coca-Cola, Crowdstrike, Kohl’s, ServiceNow, Snap and Travelers.

Chris Lange | Oct 22, 2019 at 10:20 AM EDT

Why Biogen’s Alzheimer’s Study Is Overshadowing Its Big Earnings Beat

Biogen released its third-quarter financial results and Alzheimer’s trial news before the markets opened on Tuesday.

Jon C. Ogg | Oct 19, 2019 at 6:45 AM EDT

How Biotech and Big Pharma Have Upside Heading Into Earnings

Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.

Jon C. Ogg | Oct 18, 2019 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Agilent, Alphabet, Altria, Amazon, Boeing, Caterpillar, Chipotle, E*Trade, Gap, Snap, Twitter and More

Friday's top analyst upgrades, downgrades and initiations included Agilent Technologies, Alphabet, Altria, Amazon.com, Boeing, Caterpillar, Chipotle Mexican Grill, E*Trade, Gap,…

Jon C. Ogg | Oct 17, 2019 at 9:15 AM EDT

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences,…

Chris Lange | Oct 10, 2019 at 10:00 AM EDT

Short Sellers Hike Bets in Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The September 30 short interest data…

Chris Lange | Sep 25, 2019 at 9:30 AM EDT

Major Biotechs Scare Off Short Sellers

The September 13 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Sep 12, 2019 at 8:40 AM EDT

Major Biotechs Scare Off Short Sellers

The August 30 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Aug 27, 2019 at 9:15 AM EDT

Short Sellers Hike Their Bets in Biotech

The August 15 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Aug 12, 2019 at 12:10 PM EDT

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current…

Chris Lange | Aug 12, 2019 at 8:50 AM EDT

Short Sellers Make a Move on Big Biotechs

The July 31 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Aug 8, 2019 at 1:05 PM EDT

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Of the 40 worst performers in the S&P 500 so far in 2019, 11 are tied to oil and gas,…

1 … 7 8 9 10 11 … 41

Biogen : BIIB

All Biogen Articles

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Multiple Sclerosis Treatment Wins Big FDA Approval

Major Biotechs See Rising Tide in Short Interest

Top Analysts Upgrades and Downgrades: Biogen, Coke, Crowdstrike, Kohl’s, ServiceNow, Snap, Travelers and More

Why Biogen’s Alzheimer’s Study Is Overshadowing Its Big Earnings Beat

How Biotech and Big Pharma Have Upside Heading Into Earnings

Top Analyst Upgrades and Downgrades: Agilent, Alphabet, Altria, Amazon, Boeing, Caterpillar, Chipotle, E*Trade, Gap, Snap, Twitter and More

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Short Sellers Hike Bets in Major Biotechs

Major Biotechs Scare Off Short Sellers

Major Biotechs Scare Off Short Sellers

Short Sellers Hike Their Bets in Biotech

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Short Sellers Make a Move on Big Biotechs

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Stock Market Live June 22, 2026: S&P 500 (SPY) Little Changed as Markets Wait on Iran Progress

Live Nasdaq Composite: Tech Optimism and Falling Oil Prices Set the Stage for Another Market Advance

Massive Wave of Selling Is Coming, Says JPMorgan. Here’s Why It Probably Won’t Matter

Is XRP (Ripple) Expected to Skyrocket?

Why Tesla Fatal Accidents Don’t Matter To The Company’s Success

Don't Wait For Your Rich Uncle To Die. Build Your Own Inheritance With This Portfolio

A Couple Holds $120K in Bitcoin. In a Roth It's Tax-Free. In a Brokerage Account, Selling Could Torpedo Their Social Security.

Massive Wave of Selling Is Coming, Says JPMorgan. Here’s Why It Probably Won’t Matter

Is XRP (Ripple) Expected to Skyrocket?

Biogen : BIIB

All Biogen Articles

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Multiple Sclerosis Treatment Wins Big FDA Approval

Major Biotechs See Rising Tide in Short Interest

Top Analysts Upgrades and Downgrades: Biogen, Coke, Crowdstrike, Kohl’s, ServiceNow, Snap, Travelers and More

Why Biogen’s Alzheimer’s Study Is Overshadowing Its Big Earnings Beat

How Biotech and Big Pharma Have Upside Heading Into Earnings

Top Analyst Upgrades and Downgrades: Agilent, Alphabet, Altria, Amazon, Boeing, Caterpillar, Chipotle, E*Trade, Gap, Snap, Twitter and More

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Short Sellers Hike Bets in Major Biotechs

Major Biotechs Scare Off Short Sellers

Major Biotechs Scare Off Short Sellers

Short Sellers Hike Their Bets in Biotech

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Short Sellers Make a Move on Big Biotechs

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Stock Market Live June 22, 2026: S&P 500 (SPY) Little Changed as Markets Wait on Iran Progress

Live Nasdaq Composite: Tech Optimism and Falling Oil Prices Set the Stage for Another Market Advance

Massive Wave of Selling Is Coming, Says JPMorgan. Here’s Why It Probably Won’t Matter

Is XRP (Ripple) Expected to Skyrocket?

Why Tesla Fatal Accidents Don’t Matter To The Company’s Success

Featured Reads

Don't Wait For Your Rich Uncle To Die. Build Your Own Inheritance With This Portfolio

A Couple Holds $120K in Bitcoin. In a Roth It's Tax-Free. In a Brokerage Account, Selling Could Torpedo Their Social Security.